Cargando…

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

BACKGROUND: The novel coronavirus pandemic calls for a rapid adaptation of conventional medical practices to meet the evolving needs of such vulnerable patients. People with coronavirus disease (COVID-19) may frequently require treatment with psychotropic medications, but are at the same time at hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ostuzzi, Giovanni, Papola, Davide, Gastaldon, Chiara, Schoretsanitis, Georgios, Bertolini, Federico, Amaddeo, Francesco, Cuomo, Alessandro, Emsley, Robin, Fagiolini, Andrea, Imperadore, Giuseppe, Kishimoto, Taishiro, Michencigh, Giulia, Nosé, Michela, Purgato, Marianna, Serdar, Dursun, Stubbs, Brendon, Taylor, David, Thornicroft, Graham, Ward, Philip B., Hiemke, Christoph, Correll, Christoph U., Barbui, Corrado
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360478/ https://www.ncbi.nlm.nih.gov/pubmed/32664944 http://dx.doi.org/10.1186/s12916-020-01685-9

Ejemplares similares

Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Safety of psychotropic medications in people with COVID-19
por: Ostuzzi, G., et al.
Publicado: (2021)

Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare
por: Ostuzzi, Giovanni, et al.
Publicado: (2013)

Esketamine clinical trials: reply to Maju et al.
por: Gastaldon, C., et al.
Publicado: (2020)

Esketamine for treatment resistant depression: a trick of smoke and mirrors?
por: Gastaldon, C., et al.
Publicado: (2019)

Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2022)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
por: Gastaldon, C., et al.
Publicado: (2023)

Pharmacovigilance analysis of the Vigibase on neonatal withdrawal syndrome following in utero exposure to antidepressants
por: Gastaldon, C., et al.
Publicado: (2023)

Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
por: Gastaldon, Chiara, et al.
Publicado: (2022)

Pharmacovigilance analysis of the Vigibase on antidepressants-related withdrawal syndrome in adults and adolescents
por: Gastaldon, C., et al.
Publicado: (2023)

Which psychotherapy is effective in panic disorder? Findings and reflections from a systematic network meta-analysis
por: Papola, D., et al.
Publicado: (2021)

Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses
por: Papola, Davide, et al.
Publicado: (2020)

Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises
por: Papola, Davide, et al.
Publicado: (2020)

Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies
por: Turrini, Giulia, et al.
Publicado: (2017)

CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials
por: Papola, Davide, et al.
Publicado: (2023)

Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study
por: Ostuzzi, Giovanni, et al.
Publicado: (2023)

Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

The interactions between COVID-19 drugs and psychotropic agents
por: Hiemke, C.
Publicado: (2021)

Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials
por: Papola, Davide, et al.
Publicado: (2023)

Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy
por: Ostuzzi, Giovanni, et al.
Publicado: (2018)

Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews
por: Hart, Xenia M., et al.
Publicado: (2021)

Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial
por: Turrini, G., et al.
Publicado: (2022)

Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

A network meta-analysis of psychosocial interventions for refugees and asylum seekers with PTSD
por: Turrini, Giulia, et al.
Publicado: (2021)

Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia
por: Gaebler, Arnim Johannes, et al.
Publicado: (2023)

Primary‐level and community worker interventions for the prevention of mental disorders and the promotion of well‐being in low‐ and middle‐income countries
por: Purgato, Marianna, et al.
Publicado: (2023)

Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives
por: Correll, Christoph U., et al.
Publicado: (2011)

Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval
por: Barbui, Corrado, et al.
Publicado: (2016)

Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis
por: Nosè, Michela, et al.
Publicado: (2017)

Dismantling and personalising task-sharing psychosocial interventions for common mental disorders: a study protocol for an individual participant data component network meta-analysis
por: Papola, Davide, et al.
Publicado: (2023)

Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level
por: Todesco, B., et al.
Publicado: (2022)

Forty years without mental hospitals in Italy
por: Barbui, Corrado, et al.
Publicado: (2018)

The Italian mental health-care reform: public health lessons
por: Barbui, Corrado, et al.
Publicado: (2018)

T234. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION: A STUDY-LEVEL META-ANALYSIS AND META-REGRESSION ANALYSIS
por: Rubio, Jose, et al.
Publicado: (2018)

Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis
por: Kishimoto, Taishiro, et al.
Publicado: (2023)

Safety of esketamine nasal spray: Analysis of post-marketing reports submitted to the FDA adverse event reporting system in the first year on the market
por: Gastaldon, C., et al.
Publicado: (2021)

Effects of Psychotropics on the Microbiome in Patients With Depression and Anxiety: Considerations in a Naturalistic Clinical Setting
por: Tomizawa, Yoshihiro, et al.
Publicado: (2020)

Forty-five years of schizophrenia trials in Italy: a survey
por: Purgato, Marianna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4jjbtbjbmrap7d0n1skavq6mh2